Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

News Releases

11 Jul 19
Cronos Group Enters Agreement to Acquire State-of-the-Art Fermentation and Manufacturing Facility
Facility Advances Partnership with Ginkgo Bioworks;  Will Enable Production of Cultured Cannabinoids at Commercial Scale TORONTO , July 11, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has entered into an
09 Jul 19
Cronos Group Appoints Dr. Todd Abraham as Chief Innovation Officer
36-Year CPG Executive Brings Extensive Experience in Identifying, Developing and Commercializing Breakthrough Technology for Consumer Goods Sector TORONTO , July 09, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that Dr.
08 Jul 19
Cronos Group Inc. to Hold Second Quarter 2019 Earnings Conference Call
TORONTO , July 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc.  (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results for the second quarter ended June 30, 2019, and hold its Second Quarter 2019 Earnings Conference Call on Thursday, August 8,

SEC Filings

Filing date Description

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Events

26 March 2019 at 8:30 AM EDT
Fourth Quarter 2018 and Full Year 2018 Earnings Conference Call
23 January - 25 January 2019
CIBC 22nd Annual Whistler Institutional Investor Conference
07 December 2018 at 8:30 AM EST
Strategic Partnership with Altria Conference Call